Clinical Trial Details
| Trial ID: | L5203 |
| Source ID: | NCT00425490 |
| Associated Drug: | Sitagliptin |
| Title: | Effect of Januvia on Beta Cell Function in Patients With Diabetes Mellitus |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes Mellitus Type 2 |
| Interventions: | DRUG: sitagliptin |
| Outcome Measures: | Primary: FPG,|HbA1c,|β-cell Function Parameters(Φs, Φd, Φb, Φ, Φob, T), Insulin Secretion Rate (determined from C-peptide deconvolution), 1st and 2nd phase insulin secretion, Insulin response after arginine injection, Insulin sensitivity index, glucose, insulin,|C-peptide total and incremental area under the curve. | |
| Sponsor/Collaborators: | Sponsor: Sheba Medical Center |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE3 |
| Enrollment: | 30 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT |
| Start Date: | 2007-01 |
| Completion Date: | 2009-07 |
| Results First Posted: | |
| Last Update Posted: | 2009-09-23 |
| Locations: | Sheba_Medical_Center, Tel Hashomer, Israel |
| URL: | https://clinicaltrials.gov/show/NCT00425490 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|